Obsidian Therapeutics, Inc. – Trademark Portfolio

Entity Type: 03

Obsidian Therapeutics, Inc. holds 24 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 16 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 7 trademarks are registered and 4 are pending. Notable registered marks include CYTOTIL, OBSIDIAN, CYTODRIVE, CYTOTIL15, and OBSIDIAN THERAPEUTICS. The owner is based in Cambridge, MA.

1030 Massachusetts Avenue, Fourth Floor

Cambridge, MA 02138

24 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Obsidian Therapeutics, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (16 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (11 filings)

Scientific and technological services; industrial analysis and research services

1
Chemicals (5 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

40
Treatment & Processing (4 filings)

Treatment of materials

Frequently Asked Questions

How many trademarks does Obsidian Therapeutics, Inc. have?

Obsidian Therapeutics, Inc. has 24 U.S. trademarks filed with the USPTO. Of these, 7 registered, 4 pending, 10 abandoned, 3 cancelled.

What trademark classes does Obsidian Therapeutics, Inc. file in?

Obsidian Therapeutics, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 1 (Chemicals), Class 40 (Treatment & Processing). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Obsidian Therapeutics, Inc.'s most well-known trademarks?

Obsidian Therapeutics, Inc.'s registered trademark portfolio includes well-known marks such as CYTOTIL, OBSIDIAN, CYTODRIVE, CYTOTIL15, and OBSIDIAN THERAPEUTICS. These are among 7 currently registered trademarks in the portfolio.

What is Obsidian Therapeutics, Inc.'s trademark registration success rate?

Obsidian Therapeutics, Inc. has a 35% trademark registration rate, with 7 out of 20 resolved applications resulting in successful registration. Currently, 4 applications are pending review.